In AD mice, reducing total cofilin expression, blocking cofilin activation by reducing expression of an upstream component (RanBP9) of SSH1 activation, or administering cell-penetrating peptides that inhibit cofilin dephosphorylation all reduce rod pathology as well as reverse cognitive deficits [99,303,304]. This evidence concerns the gene CFL1 and Alzheimer disease.